GWENDOLYN GRIMES: Open Payments
NPI 1346265923 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 3 payments from 3 companies in 2025. Trend: 2023 $112 · 2024 $0 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $135 |
| Alnylam Pharmaceuticals Inc. | 1 | $108 |
| Exeltis, USA Inc. | 1 | $103 |
Products named: AUSTEDO XR, AMVUTTRA, TWIRLA.
Industry payments across TX — which companies pay providers there.
